Abbot Financial Management, Inc. Merck & Co., Inc. Transaction History

Abbot Financial Management, Inc.

$197 Million
Q4 2024

A detailed history of Abbot Financial Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abbot Financial Management, Inc. holds 32,008 shares of MRK stock, worth $2.86 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

32,008

Previous 31,502 1.61%

Holding current value

$2.86 Million

Previous $3.58 Million 10.99%

% of portfolio

1.61%

Previous 1.84%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$96.31 - $114.76 $48,732 - $58,068	506 Added 1.61%	32,008 $3.18 Million
Q3 2024 Nov 08, 2024	BUY	$111.15 - $128.97 $54,463 - $63,195	490 Added 1.58%	31,502 $3.58 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $18,074 - $19,412	-146 Reduced 0.47%	31,012 $3.84 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $24,686 - $28,765	-218 Reduced 0.69%	31,158 $4.11 Million
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $107,893 - $117,414	1,077 Added 3.55%	31,376 $3.42 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $100,067 - $111,128	-972 Reduced 3.11%	30,299 $3.12 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $104,156 - $113,526	-959 Reduced 2.98%	31,271 $3.61 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $69,381 - $77,415	-674 Reduced 2.05%	32,230 $3.43 Million
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $200,937 - $257,628	-2,298 Reduced 6.53%	32,904 $3.65 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $6,424 - $7,216	76 Added 0.22%	35,202 $3.03 Million
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $16,864 - $19,117	202 Added 0.58%	35,126 $3.2 Million
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $3,601 - $4,037	-49 Reduced 0.14%	34,924 $2.87 Million
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $99,457 - $124,583	-1,376 Reduced 3.79%	34,973 $2.68 Million
Q3 2021 Nov 04, 2021	SELL	$71.68 - $78.83 $26,808 - $29,482	-374 Reduced 1.02%	36,349 $2.73 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $17,858 - $19,753	254 Added 0.7%	36,723 $2.86 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $81,323 - $95,790	1,181 Added 3.35%	36,469 $2.81 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $35,956 - $39,904	501 Added 1.44%	35,288 $2.89 Million
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $2,414 - $2,737	33 Added 0.09%	34,787 $2.89 Million
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $27,956 - $31,811	-397 Reduced 1.13%	34,754 $2.69 Million
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $19,704 - $27,312	311 Added 0.89%	35,151 $2.71 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $77 - $87	1 Added 0.0%	34,840 $3.17 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $7,455 - $8,127	-98 Reduced 0.28%	34,839 $2.93 Million
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $90,372 - $105,577	-1,294 Reduced 3.57%	34,937 $2.93 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $13,776 - $15,713	-198 Reduced 0.54%	36,231 $3.01 Million
Q4 2018 Feb 07, 2019	SELL	$65.24 - $75.71 $65,174 - $75,634	-999 Reduced 2.67%	36,429 $2.78 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $115 - $135	2 Added 0.01%	37,428 $2.66 Million
Q2 2018 Aug 09, 2018	SELL	$50.83 - $59.72 $35,479 - $41,684	-698 Reduced 1.83%	37,426 $2.27 Million
Q1 2018 May 02, 2018	BUY	$50.96 - $59.23 $103,295 - $120,059	2,027 Added 5.62%	38,124 $2.08 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $99,368 - $118,657	1,925 Added 5.63%	36,097 $2.03 Million
Q3 2017 Oct 25, 2017	BUY	$58.67 - $63.13 $2 Million - $2.16 Million	34,172	34,172 $2.16 Million

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abbot Financial Management, Inc. with notifications on news.

Account

Abbot Financial Management, Inc. Merck & Co., Inc. Transaction History